The Ritlecitinib Pregnancy Registry

Join the study to help researchers learn about the safety of using Litfulo™ (ritlecitinib) for the treatment of alopecia areata during pregnancy. A pregnancy registry is a study that collects health information from women who use prescription medicines or vaccines when they are pregnant. Information is also collected from pregnant patients who take other medications or no medications and from the newborn baby.

Would you like to participate?

Am I eligible?

You may be eligible if you:

  • Are currently pregnant or were pregnant within the past year
  • Are a resident of the United States
  • Have been diagnosed with alopecia areata by a healthcare provider

How do I participate?

Consent to contact

Complete the consent to contact card here a registry team member will contact you

Email the registry team with your contact information at:

Call the registry team

Call the registry team toll-free at
1-877-390-2940 (hours of operation 8.30am – 5.00 pm EST Monday-Friday)

What is Litfulo™ (ritlecitinib)?

Litfulo™ is a medication made by Pfizer, Inc. that is used to treat severe alopecia areata in individuals aged 12 years or older.

Future pregnant individuals, doctors, and researchers can benefit from the information you provide to the registry.

If you are eligible and would like to participate, you will be asked to:

  1. Provide your consent (a requirement for participation in any research study)
  2. Give the registry permission to contact your healthcare provider(s) to collect information for the study

You and your healthcare provider(s) will provide information to the registry about your pregnancy and your baby’s health up to 1 year of age. This information can be provided by completing paper forms, via the free registry app, via the website portal, or via short phone interviews with one of the registry team members. Only information usually documented in your medical record will be collected.

If you participate, there will be:

  • No extra doctor’s visits or additional testing
  • No changes to your existing healthcare provider(s) or care

You and your healthcare provider(s) will receive compensation for providing information to the registry.

If you are eligible and would like to participate, you will be asked to provide information to the registry at enrollment, including basic demographic information about yourself (e.g., race, ethnicity, education), height and weight and information about your history of alopecia areata.

The rest of the information will be collected from your healthcare providers periodically throughout your pregnancy. Information will also be collected from your infant’s healthcare providers periodically throughout their first year of life.

You will be paid for the data you provide to the registry.

Would you like to participate?

Register
Register